China's National Essential Medicines List (2026 edition) takes effect today, Sept. 1. Issued by the National Health Commission, the National Administration of Traditional Chinese Medicine and the National Disease Control Bureau, the list—used as the basis for drug allocation and use in medical institutions—adds 68 chemical drugs and biologics. The update targets high‑incidence chronic and common diseases and broadens covered disease categories, with a specific emphasis on increasing the range of

China's National Essential Medicines List (2026 edition) takes effect today, Sept. 1. Issued by the National Health Commission, the National Administration of Traditional Chinese Medicine and the National Disease Control Bureau, the list—used as the basis for drug allocation and use in medical institutions—adds 68 chemical drugs and biologics. The update targets high‑incidence chronic and common diseases and broadens covered disease categories, with a specific emphasis on increasing the range of pediatric‑appropriate medicines.